272 N Manabe et al.factor-related ligand signal<strong>in</strong>g pathway <strong>in</strong> granulosa cellapoptosis dur<strong>in</strong>g atresia <strong>in</strong> pig ovaries. J Reprod Dev 49,313–321.Inoue N, Maeda A, Matsuda-M<strong>in</strong>ehata F, Fukuta K, ManabeN, 2006: Expression and localization of Fas ligand and Fasdur<strong>in</strong>g atresia <strong>in</strong> porc<strong>in</strong>e ovarian follicles. J Reprod Dev 52,723–730.Inoue N, Matsuda-M<strong>in</strong>ehata F, Manabe N, 2007: Molecularcharacteristics of porc<strong>in</strong>e Fas-associated death doma<strong>in</strong>(FADD) and procaspase-8. J Reprod Dev 53, 427–436.Irmler M, Thome M, Hahne M, Schneider P, Hofmann K,Ste<strong>in</strong>er V, Bodmer JL, Schroter M, Burns K, Mattmann C,Rimoldi D, French LE, Tschopp J, 1997: Inhibition of deathreceptor signals by cellular FLIP. Nature 388, 190–195.Kaipia A, Hsueh AJ, 1997: Regulation of ovarian follicleatresia. Ann Rev Physiol 59, 349–363.Krueger A, Baumann S, Krammer PH, Kirchhoff S, 2001:FLICE-<strong>in</strong>hibitory prote<strong>in</strong>s: regulators of death receptormediatedapoptosis. Mol Cell Biol 21, 8247–8254.Maeda A, Inoue N, Matsuda-M<strong>in</strong>ehata F, Cheng Y, ManabeN, 2007a: The role of <strong>in</strong>terleuk<strong>in</strong>-6 <strong>in</strong> the regulation ofgranulosa cell apoptosis dur<strong>in</strong>g follicular atresia <strong>in</strong> pigovaries. J Reprod Dev 53, 481–490.Maeda A, Goto Y, Matsuda-M<strong>in</strong>ehata F, Cheng Y, Inoue N,Manabe N, 2007b: Changes <strong>in</strong> expression of <strong>in</strong>terleuk<strong>in</strong>-6receptors <strong>in</strong> granulosa cells dur<strong>in</strong>g follicular atresia <strong>in</strong> pigovaries. J Reprod Dev 53, 727–736.Manabe N, Imai Y, Ohno H, Takahagi Y, Sugimoto M,Miyamoto H, 1996a: Apoptosis occurs <strong>in</strong> granulosa cells butnot cumulus cells <strong>in</strong> the atretic antral follicles <strong>in</strong> pig ovaries.Experientia 52, 647–651.Manabe N, Imai Y, Kimura Y, Myoumoto A, Sugimoto M,Miyamoto H, 1996b: Ca 2+ ⁄ Mg 2+ -dependent endonucleasebut not Ca 2+ -dependent, Mg 2+ -dependent or cation-<strong>in</strong>dependentendonuclease is <strong>in</strong>volved <strong>in</strong> granulosa cell apoptosisof pig atretic follicles. J Reprod Dev 42, 247–253.Manabe N, Myoumoto A, Tajima C, Fukumoto M, NakayamaM, Uchio K, Yamaguchi M, Miyamoto H, 2000:Immunochemical characteristics of a novel cell deathreceptor and a decoy receptor on granulosa cells of porc<strong>in</strong>eovarian follicles. Cytotechnology 33, 189–201.Manabe N, Inoue N, Miyano T, Sakamaki K, Sugimoto M,Myamoto H, 2003: Ovarian follicle selection <strong>in</strong> mammalianovaries: regulatory mechanisms of granulosa cell apoptosisdur<strong>in</strong>g follicular atresia. In: Leung PK, Adashi E (eds), TheOvary, 2nd edn. Academic Press and Elsevier, Amsterdam,pp. 369–385.Manabe N, Goto Y, Matsuda-M<strong>in</strong>ehata F, Inoue N, MaedaA, Sugimoto M, Sakamaki K, Miyano T, 2004: Regulationmechanism of selective atresia <strong>in</strong> porc<strong>in</strong>e follicles: regulationof granulosa cell apoptosis dur<strong>in</strong>g atresia. J Reprod Dev 50,493–514.Matsuda-M<strong>in</strong>ehata F, Goto Y, Inoue N, Manabe N, 2005:Changes <strong>in</strong> expression of anti-apoptotic prote<strong>in</strong>, cFLIP, <strong>in</strong>granulosa cell dur<strong>in</strong>g follicular atresia <strong>in</strong> porc<strong>in</strong>e ovaries.Mol Reprod Dev 72, 145–151.Matsuda-M<strong>in</strong>ehata F, Inoue N, Goto Y, Manabe N, 2006:The regulation of ovarian granulosa cell death by pro- andanti-apoptotic molecules. J Reprod Dev 52, 695–705.Matsuda-M<strong>in</strong>ehata F, Goto Y, Inoue N, Sakamaki K, PChedrese PJ, Manabe N, 2007: Anti-apoptotic activity ofporc<strong>in</strong>e cFLIP <strong>in</strong> ovarian granulosa cell l<strong>in</strong>es. Mol ReprodDev 74, 1165–1170.Matsuda-M<strong>in</strong>ehata F, Maeda A, Cheng Y, Sai T, Gonda H,Manabe N, 2008: Regulation of granulosa cell apoptosis bydeath ligand-receptor signal<strong>in</strong>g. Anim Sci J 79, 1–10.Matsui T, Manabe N, Goto Y, Inoue N, Nishihara S,Miyamoto H, 2003: Expression and activity of Apaf1 andcaspase-9 <strong>in</strong> granulosa cells dur<strong>in</strong>g follicular atresia <strong>in</strong> pigovaries. <strong>Reproduction</strong> 126, 113–120.Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, MannM, Krammer PH, Peter ME, 1997: FLICE is activated byassociation with the CD95 death-<strong>in</strong>duc<strong>in</strong>g signal<strong>in</strong>g complex(DISC). EMBO J 16, 2794–2804.Muzio M, Ch<strong>in</strong>naiyan AM, Kischkel FC, O’Rourke K,Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, GentzR, Mann M, Krammer PH, Peter ME, Dixit VM, 1996:FLICE, a novel FADD-homologous ICE ⁄ CED-3-like protease,is recruited to the CD95 (Fas ⁄ APO-1) death-<strong>in</strong>duc<strong>in</strong>gsignal<strong>in</strong>g complex. Cell 85, 817–827.Nagata S, 1997: Apoptosis by death factor. Cell 88, 355–365.Nakayama M, Manabe N, Inoue N, Matsui T, Miyamoto H,2003: Changes <strong>in</strong> the expression of tumor necrosis factor(TNF)a, TNFa receptor (TNFR) 2, TNFR-associatedfactor 2 <strong>in</strong> granulosa cells dur<strong>in</strong>g atresia <strong>in</strong> pig ovaries. BiolReprod 68, 530–535.Nishi Y, Yanase T, Mu Y, Oba K, Ich<strong>in</strong>o I, Saito M, NomuraM, Mukasa C, Okabe T, Goto K, Takayanagi R, KashimuraY, Haji M, Nawata H, 2001: Establishment andcharacterization of a steroidogenic human granulosa-liketumor cell l<strong>in</strong>e, KGN, that expresses functional folliclestimulat<strong>in</strong>ghormone receptor. Endocr<strong>in</strong>ology 142, 437–445.Porter DA, Vickers SL, Cowan RG, Huber SC, Quirk SM,2000: Expression and function of Fas antigen vary <strong>in</strong> bov<strong>in</strong>egranulosa and theca cells dur<strong>in</strong>g ovarian follicular developmentand atresia. Biol Reprod 62, 62–66.Porter DA, Harman RM, Cowan RG, Quirk SM, 2001:Relationship of Fas ligand expression and atresia dur<strong>in</strong>gbov<strong>in</strong>e follicle development. <strong>Reproduction</strong> 121, 561–566.Sakamaki K, Yoshida H, Nishimura Y, Nishikawa S, ManabeN, Yonehara S, 1997: Involvement of Fas antigen <strong>in</strong> ovarianfollicular atresia and luteolysis. Mol Reprod Dev 47, 11–18.Schwartzman RA, Cidlowski JA, 1993: Apoptosis: the biochemistryand molecular biology of programmed cell death.Endocr Rev 14, 133–151.Thome M, Tschopp J, 2001: Regulation of lymphocyteproliferation and death by FLIP. Nat Rev Immunol 1, 50–58.Thome M, Schneider P, Hofmann K, Fickenscher H, Me<strong>in</strong>l E,Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M,Scaffidi C, Krammer PH, Peter ME, Tschopp J, 1997: ViralFLICE-<strong>in</strong>hibitory prote<strong>in</strong>s (FLIPs) prevent apoptosis<strong>in</strong>duced by death receptors. Nature 386, 517–521.Tilly JL, Kowalski KI, Johnson AL, Hsueh AJ, 1991:Involvement of apoptosis <strong>in</strong> ovarian follicular atresia andpostovulatory regression. Endocr<strong>in</strong>ology 129, 2799–2801.Wada S, Manabe N, Inoue N, Nakayama M, Matsui T,Miyamoto H, 2002: TRAIL-decoy receptor-1 disappears <strong>in</strong>granulosa cells of atretic follicles <strong>in</strong> porc<strong>in</strong>e ovaries. JReprod Dev 48, 167–173.Wallach D, Varfolomeev EE, Mal<strong>in</strong><strong>in</strong> NL, Goltsev YV,Kovalenko AV, Bold<strong>in</strong> MP, 1999: Tumor necrosis factorreceptor and Fas signal<strong>in</strong>g mechanisms. Ann Rev Immunol17, 331–367.Author’s address (for correspondence): N Manabe, Animal ResourceScience Center, University of Tokyo, Kasama 319-0206, Japan.E-mail: amanabe@mail.ecc.u-tokyo.ac.jpConflict of <strong>in</strong>terest: The authors declare no conflict of <strong>in</strong>terests.Ó 2008 The Authors. Journal compilation Ó 2008 Blackwell Verlag
Reprod Dom Anim 43 (Suppl. 2), 273–279 (2008); doi: 10.1111/j.1439-0531.2008.01174.xISSN 0936-6768Epigenetic Programm<strong>in</strong>g of Porc<strong>in</strong>e Endometrial Function and the Lactocr<strong>in</strong>eHypothesisFF Bartol 1 , AA Wiley 1 and CA Bagnell 21 Departments of Animal Sciences and Anatomy, Physiology and Pharmacology, Cellular and Molecular Biosciences Program, Auburn University,Auburn, AL, USA; 2 Department of Animal Sciences, Endocr<strong>in</strong>ology and Animal Biosciences Program, Rutgers University, New Brunswick, NJ, USAContentsEpigenetic programs controll<strong>in</strong>g development of the femalereproductive tract (FRT) are <strong>in</strong>fluenced by the effects ofnaturally occurr<strong>in</strong>g bioactive agents on patterns of geneexpression <strong>in</strong> FRT tissues dur<strong>in</strong>g organizationally criticalperiods of foetal and per<strong>in</strong>atal life. Aberrations <strong>in</strong> suchimportant cellular and molecular events, as may occur withexposure to natural or manmade steroid or peptide receptormodulat<strong>in</strong>gagents, disrupt the developmental program andcan change the developmental trajectory of FRT tissues,<strong>in</strong>clud<strong>in</strong>g the endometrium, with last<strong>in</strong>g consequences. In thepig, as <strong>in</strong> other mammals, maternal programm<strong>in</strong>g of FRTdevelopment beg<strong>in</strong>s pre-natally and is completed postnatally,when maternal effects on development can becommunicated via signals transmitted <strong>in</strong> milk. Studies<strong>in</strong>volv<strong>in</strong>g relax<strong>in</strong> (RLX), a prototypic milk-borne morphoregulatoryfactor (MbF), serve as the basis for ongo<strong>in</strong>gefforts to identify maternal programm<strong>in</strong>g events that affectuter<strong>in</strong>e and cervical tissues <strong>in</strong> the neonatal pig. Data supportthe lactocr<strong>in</strong>e hypothesis for delivery of MbFs to neonatesas a specific consequence of nurs<strong>in</strong>g. Components of amaternally driven lactocr<strong>in</strong>e mechanism for RLX-mediatedsignall<strong>in</strong>g <strong>in</strong> neonatal FRT tissues, <strong>in</strong>clud<strong>in</strong>g evidence thatmilk-borne RLX is delivered <strong>in</strong>to the neonatal circulationwhere it can act on RLX receptor (RXFP1) -positiveneonatal tissues to affect their development, are <strong>in</strong> place <strong>in</strong>the pig. The fact that all newborn mammals dr<strong>in</strong>k milkextends the timeframe of maternal <strong>in</strong>fluence on neonataldevelopment across many species. Thus, lactocr<strong>in</strong>e transmissionof milk-borne developmental signals is an element ofthe maternal epigenetic programm<strong>in</strong>g equation that deservesfurther study.IntroductionIn the pig (Sus scrofa domesticus), as <strong>in</strong> other mammals,development of the female reproductive tract (FRT)beg<strong>in</strong>s pre-natally but is completed post-natally (Y<strong>in</strong>and Ma 2005; Bartol et al. 2006). Structural pattern<strong>in</strong>g(morphogenesis) and functional programm<strong>in</strong>g (cytodifferentiation)of epithelial-mesenchymal tissues derivedfrom the Mu¨llerian ducts, <strong>in</strong>clud<strong>in</strong>g the oviducts, uterus,cervix and anterior vag<strong>in</strong>a, are coupled processessupported by the progressive generation of <strong>in</strong>creas<strong>in</strong>glycomplex and specific cellular relationships and <strong>in</strong>teractions(Gray et al. 2001; Y<strong>in</strong> and Ma 2005). Over time,these <strong>in</strong>teractions drive the evolution of organizationallycritical, temporally and spatially unique morphoregulatorygene expression doma<strong>in</strong>s that def<strong>in</strong>e micro-environmentalconditions which, <strong>in</strong> turn, direct and specifycell fate, dictate patterns of development, and determ<strong>in</strong>ecell and tissue identity and functionality. For a giventissue, this complex sequence of events def<strong>in</strong>es thedevelopmental program and, <strong>in</strong> so do<strong>in</strong>g, establishes adevelopmental trajectory for cells and tissues that willeventually dictate phenotype (Burggren 1999).Genetic potential for developmental success is def<strong>in</strong>edat conception. Thereafter, if development proceedsalong a normal course through embryonic, foetal andper<strong>in</strong>atal life, a normal phenotypic trajectory is establishedand an optimal phenotypic outcome is realized(Fig. 1). However, developmental programs can bedisrupted by a host of epigenetic factors of both biotic(physiological, endocr<strong>in</strong>ological, metabolic) and abiotic(anthropogenic ⁄ macro-environmental) orig<strong>in</strong> (Burggren1999; Bartol 2002). Disruption of the developmentalprogram dur<strong>in</strong>g organizationally critical periods, whencells and tissues are uniquely sensitive to aberrantstimuli, alters micro-environmental conditions requiredfor normal development. Divergence from the normaldevelopmental program can be sufficient to alter thedevelopmental trajectory and, ultimately, the phenotypeof a cell, tissue or organ (Fig. 1) (Bartol et al. 1999;Bartol 2002; Nathanielsz 2006). A wealth of evidence<strong>in</strong>dicates that exposure to organizationally disruptiveconditions dur<strong>in</strong>g per<strong>in</strong>atal life can have last<strong>in</strong>g effectson both the form and function of FRT tissues (Y<strong>in</strong> andMa 2005; Bartol et al. 2006). Factors required toestablish a normal developmental program and to<strong>in</strong>sure an optimal developmental trajectory for FRTtissues rema<strong>in</strong> <strong>in</strong>completely def<strong>in</strong>ed.The term epigenetics, co<strong>in</strong>ed by Wadd<strong>in</strong>gton <strong>in</strong> the1940s, was orig<strong>in</strong>ally def<strong>in</strong>ed to describe the <strong>in</strong>teractionsof genes with their environment which give rise tophenotype (Wadd<strong>in</strong>gton 1940). This def<strong>in</strong>ition hasevolved to describe the study of changes <strong>in</strong> geneexpression that occur without a change <strong>in</strong> DNAsequence (Jirtle and Sk<strong>in</strong>ner 2007). The term is nowused broadly <strong>in</strong> reference to the ‘<strong>in</strong>heritance of <strong>in</strong>formationbased on gene expression levels rather than ongene sequence’ (Junien 2006). Thus, factors that affectdevelopmentally critical gene expression events, particularlythose with last<strong>in</strong>g and potentially heritableconsequences, constitute epigenetic elements of thedevelopmental program (Jirtle and Sk<strong>in</strong>ner 2007).‘Maternal programm<strong>in</strong>g’ refers to maternally drivenepigenetic events with the potential to affect both thedevelopmental program and trajectory of embryonic,foetal and ⁄ or per<strong>in</strong>atal tissues (Szyf et al. 2005; Nathanielsz2006; Wells 2007). It is likely that maternaleffects on development do not end with parturition, butextend <strong>in</strong>to the early neonatal period. Dur<strong>in</strong>g this time,colostrum (first milk) serves as the conduit for communicationof organizationally important developmentalsignals from mother to offspr<strong>in</strong>g.Ó 2008 The Authors. Journal compilation Ó 2008 Blackwell Verlag
- Page 2 and 3:
Reproduction in Domestic AnimalsOff
- Page 5 and 6:
Reproductionin Domestic AnimalsTabl
- Page 7 and 8:
Minitüb:ProductsforArtificial Inse
- Page 9 and 10:
Reprod Dom Anim 43 (Suppl. 2), 1-7
- Page 11 and 12:
Embryo Biotechnologies in Farm Anim
- Page 13 and 14:
Embryo Biotechnologies in Farm Anim
- Page 15 and 16:
Embryo Biotechnologies in Farm Anim
- Page 17 and 18:
Ethical Models for Studying Reprodu
- Page 19 and 20:
Ethical Models for Studying Reprodu
- Page 21 and 22:
Ethical Models for Studying Reprodu
- Page 23 and 24:
Reprod Dom Anim 43 (Suppl. 2), 15-2
- Page 25 and 26:
Dietary Pollutants as Risk Factors
- Page 27 and 28:
Dietary Pollutants as Risk Factors
- Page 29 and 30:
Dietary Pollutants as Risk Factors
- Page 31 and 32:
Reprod Dom Anim 43 (Supp. 2), 23-30
- Page 33 and 34:
Factors Influencing Reproduction in
- Page 35 and 36:
Factors Influencing Reproduction in
- Page 37 and 38:
Factors Influencing Reproduction in
- Page 39 and 40:
Reprod Dom Anim 43 (Suppl. 2), 31-3
- Page 41 and 42:
GH and IGF-I in Cattle and Pigs 33h
- Page 43 and 44:
GH and IGF-I in Cattle and Pigs 35h
- Page 45 and 46:
GH and IGF-I in Cattle and Pigs 37B
- Page 47:
GH and IGF-I in Cattle and Pigs 39R
- Page 51 and 52:
Seasonality of Reproduction in Mamm
- Page 53 and 54:
Seasonality of Reproduction in Mamm
- Page 55 and 56:
Seasonality of Reproduction in Mamm
- Page 57 and 58:
Dominant Follicle Selection in Cows
- Page 59 and 60:
Dominant Follicle Selection in Cows
- Page 61 and 62:
Dominant Follicle Selection in Cows
- Page 63 and 64:
Dominant Follicle Selection in Cows
- Page 65 and 66:
Reprod Dom Anim 43 (Suppl. 2), 57-6
- Page 67 and 68:
Regulation of Luteal Function 59and
- Page 69 and 70:
Regulation of Luteal Function 61bov
- Page 71 and 72:
Regulation of Luteal Function 63(+/
- Page 73 and 74:
Regulation of Luteal Function 65sys
- Page 75 and 76:
Captive Breeding of Cheetahs in Sou
- Page 77 and 78:
Captive Breeding of Cheetahs in Sou
- Page 79 and 80:
Captive Breeding of Cheetahs in Sou
- Page 81 and 82:
Captive Breeding of Cheetahs in Sou
- Page 83 and 84:
Non-invasive Monitoring of Hormones
- Page 85 and 86:
Non-invasive Monitoring of Hormones
- Page 87 and 88:
Non-invasive Monitoring of Hormones
- Page 89 and 90:
Non-invasive Monitoring of Hormones
- Page 91 and 92:
Reprod Dom Anim 43 (Suppl. 2), 83-8
- Page 93 and 94:
Biotechnology Methods for Preservin
- Page 95 and 96:
Biotechnology Methods for Preservin
- Page 97 and 98:
Reprod Dom Anim 43 (Suppl. 2), 89-9
- Page 99 and 100:
Genetic Improvement of Dairy Cow Re
- Page 101 and 102:
Genetic Improvement of Dairy Cow Re
- Page 103 and 104:
Genetic Improvement of Dairy Cow Re
- Page 105 and 106:
Nutrient Prioritization and Fertili
- Page 107 and 108:
Nutrient Prioritization and Fertili
- Page 109 and 110:
Nutrient Prioritization and Fertili
- Page 111 and 112:
Nutrient Prioritization and Fertili
- Page 113 and 114:
CL-Endometrium-Embryo Interactions
- Page 115 and 116:
CL-Endometrium-Embryo Interactions
- Page 117 and 118:
CL-Endometrium-Embryo Interactions
- Page 119 and 120:
CL-Endometrium-Embryo Interactions
- Page 121 and 122:
Reprod Dom Anim 43 (Suppl. 2), 113-
- Page 123 and 124:
Reproductive Status Assessed by Mil
- Page 125 and 126:
Reproductive Status Assessed by Mil
- Page 127 and 128:
Reproductive Status Assessed by Mil
- Page 129 and 130:
Reproductive Status Assessed by Mil
- Page 131 and 132:
Genetic Aspects of Reproduction in
- Page 133 and 134:
Genetic Aspects of Reproduction in
- Page 135 and 136:
Genetic Aspects of Reproduction in
- Page 137 and 138:
Reprod Dom Anim 43 (Suppl. 2), 129-
- Page 139 and 140:
Nutritional Interactions and Reprod
- Page 141 and 142:
Nutritional Interactions and Reprod
- Page 143 and 144:
Nutritional Interactions and Reprod
- Page 145 and 146:
Reprod Dom Anim 43 (Suppl. 2), 137-
- Page 147 and 148:
Developmental Capabilities of Prepu
- Page 149 and 150:
Developmental Capabilities of Prepu
- Page 151 and 152:
Developmental Capabilities of Prepu
- Page 153 and 154:
Reproductive Physiology, Pathology
- Page 155 and 156:
Reproductive Physiology, Pathology
- Page 157 and 158:
Reproductive Physiology, Pathology
- Page 159 and 160:
Reproduction of Domestic Ferret 151
- Page 161 and 162:
Reproduction of Domestic Ferret 153
- Page 163 and 164:
Reproduction of Domestic Ferret 155
- Page 165 and 166:
Reprod Dom Anim 43 (Suppl. 2), 157-
- Page 167 and 168:
Canine Anoestrus, Oestrous Inductio
- Page 169 and 170:
Canine Anoestrus, Oestrous Inductio
- Page 171 and 172:
Canine Anoestrus, Oestrous Inductio
- Page 173 and 174:
Reprod Dom Anim 43 (Suppl. 2), 165-
- Page 175 and 176:
The Ethics and Role of AI in Dogs 1
- Page 177 and 178:
The Ethics and Role of AI in Dogs 1
- Page 179 and 180:
The Ethics and Role of AI in Dogs 1
- Page 181 and 182:
Control of Fertility in Females by
- Page 183 and 184:
Control of Fertility in Females by
- Page 185 and 186:
Control of Fertility in Females by
- Page 187 and 188:
Reprod Dom Anim 43 (Suppl. 2), 179-
- Page 189 and 190:
Controlling Animal Populations Usin
- Page 191 and 192:
Controlling Animal Populations Usin
- Page 193 and 194:
Controlling Animal Populations Usin
- Page 195 and 196:
Recombinant Gonadotropins in Assist
- Page 197 and 198:
Recombinant Gonadotropins in Assist
- Page 199 and 200:
Recombinant Gonadotropins in Assist
- Page 201 and 202:
Reprod Dom Anim 43 (Suppl. 2), 193-
- Page 203 and 204:
Farm Animals Embryonic Stem Cells 1
- Page 205 and 206:
Farm Animals Embryonic Stem Cells 1
- Page 207 and 208:
Farm Animals Embryonic Stem Cells 1
- Page 209 and 210:
Reproduction in Domestic Buffalo 20
- Page 211 and 212:
Reproduction in Domestic Buffalo 20
- Page 213 and 214:
Reproduction in Domestic Buffalo 20
- Page 215 and 216:
Reprod Dom Anim 43 (Suppl. 2), 207-
- Page 217 and 218:
Postpartum Ovarian Activity in Sout
- Page 219 and 220:
Postpartum Ovarian Activity in Sout
- Page 221 and 222:
Reprod Dom Anim 43 (Suppl. 2), 213-
- Page 223 and 224:
Mother-Offspring Interactions 215an
- Page 225 and 226:
Reprod Dom Anim 43 (Suppl. 2), 217-
- Page 227 and 228:
Reproduction Augmentation in Yak an
- Page 229 and 230: Reproduction Augmentation in Yak an
- Page 231 and 232: Reproduction Augmentation in Yak an
- Page 233 and 234: Follicles and Mares 2251982). Simil
- Page 235 and 236: Follicles and Mares 227Studies invo
- Page 237 and 238: Follicles and Mares 229dominant fol
- Page 239 and 240: Follicles and Mares 231trus, spring
- Page 241 and 242: Proteins in Early Equine Conceptuse
- Page 243 and 244: Proteins in Early Equine Conceptuse
- Page 245 and 246: Proteins in Early Equine Conceptuse
- Page 247 and 248: Follicular and Oocyte Competence un
- Page 249 and 250: Follicular and Oocyte Competence un
- Page 251 and 252: Follicular and Oocyte Competence un
- Page 253 and 254: Reprod Dom Anim 43 (Suppl. 2), 245-
- Page 255 and 256: Fertilization in the Porcine Fallop
- Page 257 and 258: Fertilization in the Porcine Fallop
- Page 259 and 260: Fertilization in the Porcine Fallop
- Page 261 and 262: Mastitis in Post-Partum Dairy Cows
- Page 263 and 264: Mastitis in Post-Partum Dairy Cows
- Page 265 and 266: Mastitis in Post-Partum Dairy Cows
- Page 267 and 268: Mastitis in Post-Partum Dairy Cows
- Page 269 and 270: Embryo ⁄ Foetal Losses in Ruminan
- Page 271 and 272: Embryo ⁄ Foetal Losses in Ruminan
- Page 273 and 274: Embryo ⁄ Foetal Losses in Ruminan
- Page 275 and 276: Embryo ⁄ Foetal Losses in Ruminan
- Page 277 and 278: Death Ligand and Receptor Pig Ovari
- Page 279: Death Ligand and Receptor Pig Ovari
- Page 283: Lactocrine Programming of Uterine D
- Page 286 and 287: 278 FF Bartol, AA Wiley and CA Bagn
- Page 288 and 289: Reprod Dom Anim 43 (Suppl. 2), 280-
- Page 290 and 291: 282 KC Caires, JA Schmidt, AP Olive
- Page 292 and 293: 284 KC Caires, JA Schmidt, AP Olive
- Page 294 and 295: 286 KC Caires, JA Schmidt, AP Olive
- Page 296 and 297: Reprod Dom Anim 43 (Suppl. 2), 288-
- Page 298 and 299: 290 I Dobrinskisuccessful also betw
- Page 300 and 301: 292 I DobrinskiCreemers LB, Meng X,
- Page 302 and 303: 294 I DobrinskiOkutsu T, Suzuki K,
- Page 304 and 305: 296 N Rawlings, ACO Evans, RK Chand
- Page 306 and 307: 298 N Rawlings, ACO Evans, RK Chand
- Page 308 and 309: 300 N Rawlings, ACO Evans, RK Chand
- Page 310 and 311: Reprod Dom Anim 43 (Suppl. 2), 302-
- Page 312 and 313: 304 A Dinnyes, XC Tian and X Yanggr
- Page 314 and 315: 306 A Dinnyes, XC Tian and X YangIn
- Page 316 and 317: 308 A Dinnyes, XC Tian and X YangHo
- Page 318 and 319: Reprod Dom Anim 43 (Suppl. 2), 310-
- Page 320 and 321: 312 RC Bott, DT Clopton and AS Cupp
- Page 322 and 323: 314 RC Bott, DT Clopton and AS Cupp
- Page 324 and 325: 316 RC Bott, DT Clopton and AS Cupp
- Page 326 and 327: 318 BK Whitlock, JA Daniel, RR Wilb
- Page 328 and 329: 320 BK Whitlock, JA Daniel, RR Wilb
- Page 330 and 331:
322 BK Whitlock, JA Daniel, RR Wilb
- Page 332 and 333:
Reprod Dom Anim 43 (Suppl. 2), 324-
- Page 334 and 335:
326 CR Barb, GJ Hausman and CA Lent
- Page 336 and 337:
328 CR Barb, GJ Hausman and CA Lent
- Page 338 and 339:
330 CR Barb, GJ Hausman and CA Lent
- Page 340 and 341:
332 C Galli, I Lagutina, R Duchi, S
- Page 342 and 343:
334 C Galli, I Lagutina, R Duchi, S
- Page 344 and 345:
336 C Galli, I Lagutina, R Duchi, S
- Page 346 and 347:
Reprod Dom Anim 43 (Suppl. 2), 338-
- Page 348 and 349:
340 D Rath and LA JohnsonCommercial
- Page 350 and 351:
342 D Rath and LA JohnsonThe Commer
- Page 352 and 353:
344 D Rath and LA JohnsonX- and Y-b
- Page 354 and 355:
346 D Rath and LA JohnsonWalker SK,
- Page 356 and 357:
348 JM Vazquez, J Roca, MA Gil, C C
- Page 358 and 359:
350 JM Vazquez, J Roca, MA Gil, C C
- Page 360 and 361:
352 JM Vazquez, J Roca, MA Gil, C C
- Page 362 and 363:
354 JM Vazquez, J Roca, MA Gil, C C
- Page 364 and 365:
356 CBA Whitelaw, SG Lillico and T
- Page 366 and 367:
358 CBA Whitelaw, SG Lillico and T
- Page 368 and 369:
360 ACO Evans, N Forde, GM O’Gorm
- Page 370 and 371:
362 ACO Evans, N Forde, GM O’Gorm
- Page 372 and 373:
364 ACO Evans, N Forde, GM O’Gorm
- Page 374 and 375:
366 ACO Evans, N Forde, GM O’Gorm
- Page 376 and 377:
Reprod Dom Anim 43 (Suppl. 2), 368-
- Page 378 and 379:
370 JP Kastelic and JC Thundathilsp
- Page 380 and 381:
372 JP Kastelic and JC Thundathilme
- Page 382 and 383:
Reprod Dom Anim 43 (Suppl. 2), 374-
- Page 384 and 385:
376 GC AlthouseTable 1. Potential s
- Page 386 and 387:
378 GC Althousesemen to the domesti
- Page 388 and 389:
380 B Leboeuf, JA Delgadillo, E Man
- Page 390 and 391:
382 B Leboeuf, JA Delgadillo, E Man
- Page 392 and 393:
384 B Leboeuf, JA Delgadillo, E Man
- Page 394 and 395:
Reprod Dom Anim 43 (Suppl. 2), 386-
- Page 396 and 397:
388 N Kostereva and M-C HofmannFig.
- Page 398 and 399:
390 N Kostereva and M-C HofmannMMPs
- Page 400 and 401:
392 N Kostereva and M-C HofmannTado
- Page 402 and 403:
394 P Mermillod, R Dalbie` s-Tran,
- Page 404 and 405:
396 P Mermillod, R Dalbie` s-Tran,
- Page 406 and 407:
398 P Mermillod, R Dalbie` s-Tran,
- Page 408 and 409:
400 P Mermillod, R Dalbie` s-Tran,
- Page 410 and 411:
402 K Kikuchi, N Kashiwazaki, T Nag
- Page 412 and 413:
404 K Kikuchi, N Kashiwazaki, T Nag
- Page 414 and 415:
406 K Kikuchi, N Kashiwazaki, T Nag
- Page 416 and 417:
408 B ObackNumber of publications20
- Page 418 and 419:
410 B ObackReprogramming Ability of
- Page 420 and 421:
412 B Obackstudies have shown that
- Page 422 and 423:
414 B ObackFig. 4. Climbing mount e
- Page 424 and 425:
416 B ObackRenard JP, Maruotti J, J
- Page 426 and 427:
418 P Loi, K Matzukawa, G Ptak, Y N
- Page 428 and 429:
420 P Loi, K Matzukawa, G Ptak, Y N
- Page 430 and 431:
422 P Loi, K Matzukawa, G Ptak, Y N
- Page 434:
Table of Contents Volume 43 · Supp